4//SEC Filing
BRYCE RICHARD PAUL 4
Accession 0001209191-20-045120
CIK 0001401667other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:35 PM ET
Size
4.9 KB
Accession
0001209191-20-045120
Insider Transaction Report
Form 4
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Transactions
- Sale
COMMON STOCK
2020-08-03$10.80/sh−86$929→ 76,997 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001553037
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:35 PM ET
- Size
- 4.9 KB